| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 08/19/2004 | US20040163136 SEL-12 related methods |
| 08/19/2004 | US20040162416 Expression vector for use in transformation and propagation of heterologous nucleotide sequences in eucaryotic cells; bioreactors |
| 08/19/2004 | US20040162238 using Zven1 and Zven2 polypeptides to increase chemokine production for treating intestinal motility disorders and improving gastrointestinal funciton |
| 08/19/2004 | US20040161849 Materials and methods relating to the transfer of nucleic acid into quiescent cells |
| 08/19/2004 | US20040161848 Adenoviral vector and related system and methods of making and use |
| 08/19/2004 | US20040161845 Heating apparatus |
| 08/19/2004 | US20040161844 first and second oligomers capable of hybridizing with eachother, one of which includes peptide nucleic acid or mimic, a morpholino nucleic acid, hexose sugar with amide linkage, cyclohexenyl nucleic acid or an acyclic backbone modification |
| 08/19/2004 | US20040161843 Administering a peptide fragments from proteins that function as T-cell epitopes of human cytomegalovirus(HCMV) in human are capable of directing human cytotoxic T lymphocytes (CTL) to recognize and lyse human cells to infection with HCMV |
| 08/19/2004 | US20040161836 Recombinant porcine liver esterases, their use and a method for the production thereof |
| 08/19/2004 | US20040161827 Comprises nucleotide sequences coding tumor suppression phosphoprotein for use as pesticide and in treatment of cell proliferative disorders; antitumor agents; bioreactors and in vitro/in vivo drug screening |
| 08/19/2004 | US20040161825 Sperm specific proteins |
| 08/19/2004 | US20040161824 expressed on the surface of sperm; can be used in contraceptive vaccine formulations; for drug screening; genetic engineering |
| 08/19/2004 | US20040161818 for use in pesticide bioremediation strategies; biosensors; genetic engineering; solid phase synthesis |
| 08/19/2004 | US20040161817 for gene overexpression in combination with an immortalized host cell-line capable of growth in serum-free, suspension culture |
| 08/19/2004 | US20040161814 for drug screening enzyme inhibitors using gel chromatography; bioassays; gene therapy; genetic engineering |
| 08/19/2004 | US20040161806 Cells having transferred proteins, and methods of use thereof |
| 08/19/2004 | US20040161805 Cardiovascular safety assay |
| 08/19/2004 | US20040161786 Gene panel participative in hepatic stellate cell activation |
| 08/19/2004 | US20040161781 Identifying enzyme inhibitors and modulators which bind specific transcriptional elements for use in treatment of cell proliferative disorders |
| 08/19/2004 | US20040161771 Using fluorescence activated cell sorting to identify and separate cell expressing nucleotide sequence coding transcribing interleukin-4 |
| 08/19/2004 | US20040161762 Novel human poly(a)polymerase gamma (pap gamma) |
| 08/19/2004 | US20040161757 Use of acetyl-coa carboxylase for identifying compounds that have an insecticidal effect |
| 08/19/2004 | US20040161745 Nucleotide sequences coding glucuronidase for identifying modulators for treatment of inflammation; wound healing agents and tissue repair |
| 08/19/2004 | US20040161739 HIV diagnostic methods |
| 08/19/2004 | US20040161433 Method for in vitro culture of lymphocytes and composition for use in immune therapy |
| 08/19/2004 | US20040161419 Novel cells obtained from amnion, chorion and decidual layers; expressing markers from Thy-1, OCT-4, SOX2, SSEA3, SSEA4, TRA1-60, TRA1-81, Lefty A, FGF-4, Rex-1 and/or TDGF-1 |
| 08/19/2004 | US20040161417 Inhibiting expression of invariant chain protein (li) in antigen presenting cells |
| 08/19/2004 | US20040161414 Method of curing injured spinal cord and therapeutic agents for that |
| 08/19/2004 | US20040161412 Cell-based VEGF delivery |
| 08/19/2004 | US20040161410 Involving nucleotide sequence 15 or 19; efficient, well tolerated |
| 08/19/2004 | CA2743564A1 Glyphosate tolerant alfalfa events and methods for detection thereof |
| 08/19/2004 | CA2515135A1 Breast cancer-resistant protein inhibitor |
| 08/19/2004 | CA2515123A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515100A1 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | CA2515081A1 Amphiregulin antibodies and their use to treat cancer and psoriasis |
| 08/19/2004 | CA2514810A1 Use of islet 1 as a marker for isolating or generating stem cells |
| 08/19/2004 | CA2514576A1 Methods for treating, preventing and detecting helicobacter infection |
| 08/19/2004 | CA2512624A1 Rat receptor tyrosine kinase, kdr |
| 08/19/2004 | CA2506619A1 Cell lines and host nucleic acid sequences related to infectious disease |
| 08/18/2004 | EP1447443A1 Immortalized mesenchymal cells and utilization thereof |
| 08/18/2004 | EP1447411A1 Novel protein, its dna and use thereof |
| 08/18/2004 | EP1447091A1 Novel method of inducing antigen-specific t cells |
| 08/18/2004 | EP1446495A2 Whole cell engineering using real-time metabolic flux analysis |
| 08/18/2004 | EP1446490A1 Chimeric plasmid comprising a replicative retroviral genome and uses thereof |
| 08/18/2004 | EP1446489A2 Intact minicells as vectors for dna transfer and gene therapy in vitro and in vivo |
| 08/18/2004 | EP1446488A2 Regulated nucleic acid expression system |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446486A1 Transgenic organism expressing fungal mrp-like abc transporters |
| 08/18/2004 | EP1446484A1 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same |
| 08/18/2004 | EP1446482A2 Compositions and methods for making mutations in cell lines and animals |
| 08/18/2004 | EP1446479A1 Recombinant adenovirus with enhanced therapeutic effect and pharmaceutical composition comprising said recombinant adenovirus |
| 08/18/2004 | EP1446478A2 Dimerized growth factor and materials and methods for producing it |
| 08/18/2004 | EP1446477A1 Methods of derivation and propagation of undifferentiated human embryonic stem (hes) cells on feeder-free matrices and human feeder layers |
| 08/18/2004 | EP1446476A2 Endothelial cells derived from primate embryonic stem cells |
| 08/18/2004 | EP1446426A2 Peptide purification by means of metal ion affinity chromatography |
| 08/18/2004 | EP1446422A2 Methylated heparin-binding hemagglutinin recombinant mycobacterial antigen, preparation method and immunogenic compositions comprising same |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446171A1 Augmentation of organ function |
| 08/18/2004 | EP1446162A2 Combination motif immune stimulatory oligonucleotides with improved activity |
| 08/18/2004 | EP1446159A2 Immunotherapy for reversing immune suppression |
| 08/18/2004 | EP1446143A2 Use of obg3 for promoting central nervous system remyelination |
| 08/18/2004 | EP1446133A2 Methods of improving central nervous system functioning |
| 08/18/2004 | EP1446007A1 Methods and compositions for targeting underglycosylated proteins across the blood brain barrier |
| 08/18/2004 | EP1446005A2 Cryopreservation of biological materials using pre-chilled protectant |
| 08/18/2004 | EP1071747B1 Immortalised cell lines derived from normal human skin tissues |
| 08/18/2004 | EP1045637A4 Decorated red blood cells |
| 08/18/2004 | EP1005533A4 Methods for screening nuclear transcription factors for the ability to modulate an estrogen response |
| 08/18/2004 | EP0977856B1 Lag-3 splice variants |
| 08/18/2004 | EP0954330A4 Intestinal trefoil proteins |
| 08/18/2004 | EP0951533A4 Vectors and methods for the mutagenesis of mammalian genes |
| 08/18/2004 | EP0931163A4 Assessment of intracellular cysteine and glutathione concentrations |
| 08/18/2004 | EP0866849B1 Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system |
| 08/18/2004 | EP0833920B1 Transferrin receptor genes |
| 08/18/2004 | EP0827544B1 Multimeric proteins |
| 08/18/2004 | EP0820507B1 Ndf peptides |
| 08/18/2004 | EP0742836A4 Method for separating rare cells from a population of cells |
| 08/18/2004 | EP0663014B1 Dna encoding human alpha 1 adrenergic receptors and uses thereof |
| 08/18/2004 | EP0471011B2 HUMAN LACTOFERRIN cDNA SEQUENCE |
| 08/18/2004 | CN2633892Y Space cell electra-fusion cultivation system |
| 08/18/2004 | CN1522299A Coagulation factor vii derivatives |
| 08/18/2004 | CN1522160A Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
| 08/18/2004 | CN1521257A Microencapsulated cell of human tissue kallikrein, microencapsulating method and application thereof |
| 08/18/2004 | CN1521192A Human erythropoietin Fc fusion protein with high bioactivity |
| 08/18/2004 | CN1162539C Novel cell strain of high-transferring bladder cancer and its establishing method |
| 08/18/2004 | CN1162443C Cellular injury response element and uses thereof |
| 08/18/2004 | CN1162182C Method of protein production using chondriosome translation system |
| 08/17/2004 | US6777539 Cytokine antagonists; detecting ligands that stimulate the proliferation and/or development of hematopoietic, lymphoid and myeloid cells in vitro and in vivo; immunostimulants |
| 08/17/2004 | US6777247 Nervous necrosis virus protein |
| 08/17/2004 | US6777236 Process for producing a neuronal host cell in vitro comprising regulatory sequences of the β2-subunit of the neuronal nicotinic acetylcholine receptor |
| 08/17/2004 | US6777234 Mammalian muscle construct and method for producing same |
| 08/17/2004 | US6777233 Cell culture of nervous system cells |
| 08/17/2004 | US6777231 Adipose-derived stem cells and lattices |
| 08/17/2004 | US6777230 Prostate cancer cell lines |
| 08/17/2004 | US6777208 Generating 2'-deoxyribonucleoside; obtain microorganism, transform with vector containing ribonucleotide reductase, express vector, incubate with substrate, recover 2'-deoxyribonucleoside |
| 08/17/2004 | US6777194 Monoclonal antibodies against human protein Mcm3, process for their production, and their use |
| 08/17/2004 | US6776988 Vectors for gene mutagenesis and gene discovery |
| 08/17/2004 | CA2325228C Catalytic domain of the human effector cell cycle checkpoint protein kinase, chk1, materials and methods for identification of inhibitors thereof |
| 08/17/2004 | CA2295861C Method of preparing a transgenic non-human animal expressing p25 |
| 08/17/2004 | CA2258153C Hepatocyte growth factor receptor agonists and uses thereof |
| 08/17/2004 | CA2097545C Process for the immunochemical determination of an analyte |